Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-099831

Director sold 222,603 shares at an average $46.61 ($10,375,620)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Kersten Dirk Director 2024-08-20 Sale 10b5-1 −43,057 $45.68 $1,966,844 1,080,416 I
Kersten Dirk Director 2024-08-20 Sale 10b5-1 −35,457 $46.94 $1,664,352 1,044,959 I
Kersten Dirk Director 2024-08-20 Sale 10b5-1 −8,326 $47.30 $393,820 1,036,633 I
Kersten Dirk Director 2024-08-21 Sale 10b5-1 −64,518 $46.52 $3,001,377 972,115 I
Kersten Dirk Director 2024-08-21 Sale 10b5-1 −71,245 $47.01 $3,349,227 900,870 I
Open-market sales · 222,603 sh · avg $46.61 · $10,375,620
Loading xslF345X05/ownership.xml…